Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a …
Telmisartan Randomised AssessmeNt Study in ACE … - The Lancet, 2008 - Elsevier
BACKGROUND: Angiotensin-converting enzyme (ACE) inhibitors reduce major
cardiovascular events, but are not tolerated by about 20% of patients. We therefore …
cardiovascular events, but are not tolerated by about 20% of patients. We therefore …
[引用][C] Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a …
… Study in ACE iNtolerant subjects with … - The …, 2008 - lomalinda.elsevierpure.com
Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk
patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial …
patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial …
[引用][C] Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a …
Transcend Investigators - Lancet, 2008 - researchportal.tuni.fi
Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk
patients intolerant to angiotensin-converting enzyme inhibitors:a randomised controlled trial …
patients intolerant to angiotensin-converting enzyme inhibitors:a randomised controlled trial …
Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a …
… AssessmeNt Study in ACE iNtolerant subjects … - The …, 2008 - mahidol.elsevierpure.com
Background: Angiotensin-converting enzyme (ACE) inhibitors reduce major cardiovascular
events, but are not tolerated by about 20% of patients. We therefore assessed whether the …
events, but are not tolerated by about 20% of patients. We therefore assessed whether the …
Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a …
S Yusuf, K Teo, C Anderson, J Pogue, L Dyal… - The …, 2008 - portalcientifico.uah.es
Background: Angiotensin-converting enzyme (ACE) inhibitors reduce major cardiovascular
events, but are not tolerated by about 20% of patients. We therefore assessed whether the …
events, but are not tolerated by about 20% of patients. We therefore assessed whether the …
Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a …
S Yusuf, K Teo, C Anderson, J Pogue… - The …, 2008 - produccioncientifica.ucm.es
Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk
patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial …
patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial …
Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a …
… Study in ACE iNtolerant subjects with … - The …, 2008 - utsouthwestern.elsevierpure.com
Background: Angiotensin-converting enzyme (ACE) inhibitors reduce major cardiovascular
events, but are not tolerated by about 20% of patients. We therefore assessed whether the …
events, but are not tolerated by about 20% of patients. We therefore assessed whether the …
Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a …
S Yusuf, K Teo, C Anderson, J Pogue, L Dyal… - Lancet, 2008 - zora.uzh.ch
BACKGROUND: Angiotensin-converting enzyme (ACE) inhibitors reduce major
cardiovascular events, but are not tolerated by about 20% of patients. We therefore …
cardiovascular events, but are not tolerated by about 20% of patients. We therefore …
Effects of the angiotensi-receptor blocker telmisartan on cardiovascular events in hight risk pATIENTS INTOLLERANT TO ANGIOTENSIN-CONVERTING ENZYME …
S Yusuf, K Teo, C Anderson, J Pogue, L Dyal… - THE LANCET, 2008 - sfera.unife.it
Background Angiotensin-converting enzyme (ACE) inhibitors reduce major cardiovascular
events, but are not tolerated by about 20% of patients. We therefore assessed whether the …
events, but are not tolerated by about 20% of patients. We therefore assessed whether the …
[引用][C] Effects of the angiotensin-receptor blockertelmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a …
TL RIPLEY, D HARRISON - Lancet (British edition), 2008 - pascal-francis.inist.fr
Effects of the angiotensin-receptor blockertelmisartan on cardiovascular events in high-risk
patients intolerant to angiotensin-converting enzyme inhibitors : a randomised controlled …
patients intolerant to angiotensin-converting enzyme inhibitors : a randomised controlled …